author-photo

Chin-Hin Ng

University College London Hospitals NHS Foundation Trust

3

Papers

9

Citations

Citation Trend

Filter By

Papers (3) Sort By

Journal Conference Others

A Dose-Escalation (DE) Study with Expansion Evaluating Safety, Pharmacokinetics and Efficacy of the Novel, Balanced PI3K/mTOR Inhibitor PQR309 in Patients with Relapsed or Refractory Lymphoma

2016 Blood
Show All
- Source
- Cite
- Save
Citations (5)
Clinical Outcomes of Phase I/II Clinical Trials for Patients with Relapsed/Refractory Haematological Malignancies: Experience of an Early Phase Clinical Trials Unit

2016 Blood
Show All
- Source
- Cite
- Save
Citations (0)
A Phase I Dose-Escalation Study of the Class 1 Selective Histone Deacetylase Inhibitor CHR-3996 in Combination with Tosedostat for Patients with Relapsed, Refractory Multiple Myeloma: Results of the Muk Three Trial

2016 Blood
Show All
- Source
- Cite
- Save
Citations (4)